Pharmacokinetic concepts for TCI anaesthesia

Area of Science:

• Anesthesiology
• Pharmacology
• Clinical Pharmacy

Background:

• Advancements in short-acting anesthetics, drug assay techniques, and infusion systems have propelled clinical pharmacokinetics and pharmacodynamics.
• Tri-exponential drug decay complicates dosage regimens and recovery prediction.
• Effect-site equilibration time causes a delay between drug concentration and effect, especially with incremental dosing.

Purpose of the Study:

• To explore the utility of context-sensitive half-time for predicting drug concentration decline after infusion.
• To understand the role of effect-site equilibration time in drug effect dynamics.
• To evaluate the principles of drug infusion for reducing concentration and effect fluctuations.

Main Methods:

• Utilizing pharmacokinetic and pharmacodynamic principles to model drug behavior.
• Employing context-sensitive half-time as a predictive measure for drug elimination.
• Investigating the impact of effect-site equilibration time on drug response.
• Applying target-controlled infusion (TCI) devices for precise drug delivery.

Main Results:

• Context-sensitive half-time offers a valuable comparative predictor of drug concentration decline post-infusion.
• Effect-site equilibration time is a key factor in the delay and disequilibrium of drug effects.
• Drug infusion aims to minimize fluctuations in drug concentrations and effects.
• Target-controlled infusion devices enable individualized titration of anesthetic concentration against clinical effect.

Conclusions:

• Pharmacokinetic modeling and context-sensitive half-time are crucial for managing short-acting anesthetic infusions.
• Target-controlled infusion, guided by pharmacokinetic principles, allows for precise and individualized anesthetic management.
• Optimizing infusion strategies can achieve desired drug concentration and effect variability, similar to inhalation agents.